Akido raises $60 million in Series B funding to enhance ScopeAI, their innovative health AI solution. This investment will support Akido's mission to democratize high-quality healthcare worldwide.
Akido raises $60 million in Series B funding to enhance ScopeAI, their innovative health AI solution. This investment will support Akido's mission to democratize high-quality healthcare worldwide.
05/15/25, 4:50 PM
Location
los angelesMoney raised
$60 million
Industry
machine learning
medical
artificial intelligence
biotechnology
health care
Round Type
series b
Akido has successfully raised $60 million in Series B funding to further develop ScopeAI, a revolutionary health AI product. This technology addresses the global physician shortage by empowering healthcare providers. With the additional funding, Akido aims to increase access to care and improve service quality. The company is committed to ensuring timely healthcare is available to all, regardless of financial means or geography.
Company Info
Location
los angeles, california, united states
Additional Info
Akido is pioneering a reimagined healthcare system with AI at its core; one that bridges artificial intelligence and empathy to bring exceptional healthcare to everyone. Its breakthrough technology unlocks the ability to transform the clinical experience, empowering providers and patients through an entirely new healthcare model. Founded in 2015, Akido was created out of the University of Southern California’s Digital Health Lab with the idea that empowering government, healthcare, and nonprofit services with population-based data could help usher in a new era of preventive public health. Known for developing award-winning data and technology solutions, today Akido leverages its market-leading technology to power its bicoastal Akido Care medical network, which includes more than 240 providers and 90 clinics across both coasts and a patient base of nearly half a million.